SEC Form 4 · accession 0001209191-18-039232
Flexion Therapeutics Inc · FLXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kerry Wentworth
Officer — Chief Regulatory Officer
Period of report
Jun 20, 2018
Accepted (ET)
Jun 22, 2018 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419600
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 20, 2018 | J | 171 | $21.22 | A | 12,478 | D | |
| Common Stock | holding | — | — | — | 6,000 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 is being filed voluntarily to report the acquisition of 171 shares by the Reporting Person on June 20, 2018 pursuant to the Issuer's Employee Stock Purchase Plan.